Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 6월 2022 - 6:12AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of June 2022
Commission
File Number: 001-41115
GENENTA
SCIENCE S.P.A.
(Translation
of registrant’s name into English)
Via
Olgettina No. 58
20132
Milan, Italy
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Other
Events
On
June 13, 2022, Genenta Science S.pA. held its Ordinary and Extraordinary Shareholders Meeting in virtual meeting format. At the Ordinary
and Extraordinary Shareholders Meeting, the Company’s shareholders: (1) approved the financial statements for the Company for the
financial year ending December 31, 2021; (2) ratified the appointment of Dr. Mark A. Sirgo as a director and Chairman of the Board
of Directors of the Company; and (3) approved the amendment of the Company’s bylaws to provide an exclusive federal forum in the
United States federal courts in New York for lawsuits relating to the United States federal securities laws.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
GENENTA
SCIENCE S.P.A. |
|
|
|
|
By: |
/s/
Richard B. Slansky |
|
Name: |
Richard
B. Slansky |
|
Title: |
Chief
Financial Officer |
Dated:
June 14, 2022
Genenta Science (NASDAQ:GNTA)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 10월(10) 2024
Genenta Science (NASDAQ:GNTA)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024